We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AI Model Reveals True Biological Age From Five Drops of Blood

By LabMedica International staff writers
Posted on 19 Mar 2025

Some individuals seem to defy the effects of aging, appearing significantly younger than their peers despite sharing the same age. More...

Aging isn't solely determined by the number of years we have lived; it's also influenced by genetics, lifestyle, and environmental factors. Conventional methods of assessing biological age typically focus on broad biomarkers, like DNA methylation or protein levels. However, these techniques often overlook the complex hormonal systems that regulate the body's internal balance. Now, scientists have developed a novel approach for estimating a person’s biological age, which measures how well the body has aged rather than simply counting the years since birth.

This new method, developed by scientists at Osaka University (Osaka, Japan), uses only five drops of blood to analyze 22 key steroids and their interactions, offering a more precise health assessment. Published in Science Advances, the team’s breakthrough study presents a potential leap forward in personalized health management, enabling earlier identification of age-related health risks and more tailored interventions. Since hormones are essential for maintaining bodily functions, the researchers chose to focus on these as key indicators of aging. To test this hypothesis, the team concentrated on steroid hormones, which are vital in metabolism, immune response, and stress management.

The researchers created a deep neural network (DNN) model that incorporates steroid metabolism pathways, making it the first AI model to consider the interactions between different steroid molecules. Rather than examining absolute steroid levels—which can vary greatly between individuals—the model looks at the ratios of steroids, delivering a more personalized and accurate biological age assessment. Trained on blood samples from hundreds of individuals, the model revealed that biological age differences become more pronounced as people age, an effect the researchers liken to a river widening as it flows downstream.

One of the most surprising findings of the study concerns cortisol, a steroid hormone linked to stress. The researchers discovered that when cortisol levels doubled, biological age increased by about 1.5 times. This suggests that chronic stress could speed up aging at the biochemical level, emphasizing the importance of managing stress to maintain long-term health. The team believes that this AI-driven biological age model could lead to more personalized health monitoring.

Potential future applications for this technology include early disease detection, tailored wellness programs, and lifestyle recommendations to slow the aging process. While the study marks significant progress, the team acknowledges that biological aging is influenced by numerous factors beyond hormones. With continued advancements in AI and biomedical research, the ability to measure—and possibly slow—biological aging is becoming more attainable. For now, the capability to assess an individual’s “aging speed” with a simple blood test could be a revolutionary development in preventive healthcare.

“This is just the beginning,” said Dr. Zi Wang, co-first and corresponding author of this work. “By expanding our dataset and incorporating additional biological markers, we hope to refine the model further and unlock deeper insights into the mechanisms of aging.”

Related Links:
Osaka University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.